BioStem Technologies, Inc. (OTCMKTS:BSEM) Short Interest Up 38.8% in December

BioStem Technologies, Inc. (OTCMKTS:BSEM - Get Free Report) was the target of a large growth in short interest in December. As of December 31st, there was short interest totalling 191,200 shares, a growth of 38.8% from the December 15th total of 137,800 shares. Based on an average daily trading volume, of 98,300 shares, the short-interest ratio is presently 1.9 days.

BioStem Technologies Price Performance

Shares of OTCMKTS BSEM traded up $0.09 on Wednesday, hitting $15.60. The company's stock had a trading volume of 91,433 shares, compared to its average volume of 54,027. The stock has a 50 day moving average of $15.38 and a 200-day moving average of $12.63. The company has a market capitalization of $259.80 million, a price-to-earnings ratio of 22.94 and a beta of -0.53. BioStem Technologies has a 12-month low of $4.41 and a 12-month high of $28.26.

BioStem Technologies (OTCMKTS:BSEM - Get Free Report) last posted its earnings results on Tuesday, November 12th. The company reported $0.32 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.31 by $0.01. The company had revenue of $82.56 million during the quarter, compared to analysts' expectations of $78.22 million. Sell-side analysts expect that BioStem Technologies will post 1.41 EPS for the current fiscal year.

BioStem Technologies Company Profile

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.